Anti-tumor necrosis factor therapy improves insulin resistance, beta cell function and insulin signaling in active rheumatoid arthritis patients with high insulin resistance.docVIP

下载本文档

8
0
约4.77万字
约 11页
2017-05-15 发布于上海
举报

Anti-tumor necrosis factor therapy improves insulin resistance, beta cell function and insulin signaling in active rheumatoid arthritis patients with high insulin resistance.doc

Anti-tumor necrosis factor therapy improves insulin resistance, beta cell function and insulin signaling in active rheumatoid arthritis patients with high insulin resistance

Stagakisetal.ArthritisResearchTherapy2012,14:R141 /content/14/3/R141 RESEARCH ARTICLE OpenAccess Anti-tumornecrosisfactortherapyimproves insulinresistance,betacellfunctionandinsulin signalinginactiverheumatoidarthritispatients withhighinsulinresistance IliasStagakis1,2?,GeorgeBertsias1,2?,StylianosKarvounaris1,MelinaKavousanaki1,DimitraVirla3, AmaliaRaptopoulou1,DimitriosKardassis3,4,DimitriosTBoumpas1,2,4 andProdromosISidiropoulos1* Abstract Introduction:Prevalenceofinsulinresistanceandthemetabolicsyndromehasbeenreportedtobehighin rheumatoidarthritis(RA)patients.Tumornecrosisfactor(TNF)

您可能关注的文档

文档评论（0）

1亿VIP精品文档

更多 >

Anti-tumor necrosis factor therapy improves insulin resistance, beta cell function and insulin signaling in active rheumatoid arthritis patients with high insulin resistance.docVIP